These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9416318)

  • 21. Low dose L-NAME reduces infarct volume in the rat MCAO/reperfusion model.
    Ashwal S; Cole DJ; Osborne TN; Pearce WJ
    J Neurosurg Anesthesiol; 1993 Oct; 5(4):241-9. PubMed ID: 8251713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of alkalizing agents on experimental focal cerebral ischemia.
    Kuyama H; Kitaoka T; Fujita K; Nagao S
    Acta Neurochir Suppl (Wien); 1994; 60():325-8. PubMed ID: 7976580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early administration of a second-generation perfluorochemical decreases ischemic brain damage in a model of permanent middle cerebral artery occlusion in the rat.
    Woitzik J; Weinzierl N; Schilling L
    Neurol Res; 2005 Jul; 27(5):509-15. PubMed ID: 15978177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dietary vitamin E levels affect outcome of permanent focal cerebral ischemia in rats.
    van der Worp HB; Bär PR; Kappelle LJ; de Wildt DJ
    Stroke; 1998 May; 29(5):1002-5; discussion 1005-6. PubMed ID: 9596250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fructose-1,6-bisphosphate reduces infarct volume after reversible middle cerebral artery occlusion in rats.
    Kuluz JW; Gregory GA; Han Y; Dietrich WD; Schleien CL
    Stroke; 1993 Oct; 24(10):1576-83. PubMed ID: 8378964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats.
    Kawasaki-Yatsugi S; Yatsugi S; Takahashi M; Toya T; Ichiki C; Shimizu-Sasamata M; Yamaguchi T; Minematsu K
    Brain Res; 1998 May; 793(1-2):39-46. PubMed ID: 9630503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of ritanserin, a 5-HT2 receptor antagonist, on ischemic cerebral blood flow and infarct volume in rat middle cerebral artery occlusion.
    Takagi K; Ginsberg MD; Globus MY; Busto R; Dietrich WD
    Stroke; 1994 Feb; 25(2):481-5; discussion 485-6. PubMed ID: 8303760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endovascular suture occlusion of the middle cerebral artery in rats: effect of suture insertion distance on cerebral blood flow, infarct distribution and infarct volume.
    Zarow GJ; Karibe H; States BA; Graham SH; Weinstein PR
    Neurol Res; 1997 Aug; 19(4):409-16. PubMed ID: 9263222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute treatment with tamoxifen reduces ischemic damage following middle cerebral artery occlusion.
    Kimelberg HK; Feustel PJ; Jin Y; Paquette J; Boulos A; Keller RW; Tranmer BI
    Neuroreport; 2000 Aug; 11(12):2675-9. PubMed ID: 10976942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of RSR13, a synthetic allosteric modifier of hemoglobin, alone and in combination with dizocilpine, on outcome from transient focal cerebral ischemia in the rat.
    Sarraf-Yazdi S; Sheng H; Grocott HP; Bart RD; Pearlstein RD; Steffen RP; Warner DS
    Brain Res; 1999 May; 826(2):172-80. PubMed ID: 10224294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats.
    Kitagawa H; Hayashi T; Mitsumoto Y; Koga N; Itoyama Y; Abe K
    Stroke; 1998 Jul; 29(7):1417-22. PubMed ID: 9660398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMPA receptor antagonist, YM90K, reduces infarct volume in thrombotic distal middle cerebral artery occlusion in spontaneously hypertensive rats.
    Yao H; Ibayashi S; Nakane H; Cai H; Uchimura H; Fujishima M
    Brain Res; 1997 Apr; 753(1):80-5. PubMed ID: 9125434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraluminal suture occlusion and ligation of the distal branch of internal carotid artery: an improved rat model of focal cerebral ischemia-reperfusion.
    Chu X; Qi C; Zou L; Fu X
    J Neurosci Methods; 2008 Feb; 168(1):1-7. PubMed ID: 18029024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The glycine antagonist GV150526 protects somatosensory evoked potentials and reduces the infarct area in the MCAo model of focal ischemia in the rat.
    Bordi F; Pietra C; Ziviani L; Reggiani A
    Exp Neurol; 1997 Jun; 145(2 Pt 1):425-33. PubMed ID: 9217078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-NAME reduces infarct volume in a filament model of transient middle cerebral artery occlusion in the rat pup.
    Ashwal S; Cole DJ; Osborne S; Osborne TN; Pearce WJ
    Pediatr Res; 1995 Nov; 38(5):652-6. PubMed ID: 8552429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase.
    Buchan AM; Gertler SZ; Huang ZG; Li H; Chaundy KE; Xue D
    Neuroscience; 1994 Jul; 61(1):1-11. PubMed ID: 7526264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mild hypothermia reduces infarct size resulting from temporary but not permanent focal ischemia in rats.
    Ridenour TR; Warner DS; Todd MM; McAllister AC
    Stroke; 1992 May; 23(5):733-8. PubMed ID: 1579972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative histopathologic consequences of photothrombotic occlusion of the distal middle cerebral artery in Sprague-Dawley and Wistar rats.
    Markgraf CG; Kraydieh S; Prado R; Watson BD; Dietrich WD; Ginsberg MD
    Stroke; 1993 Feb; 24(2):286-92; discussion 292-3. PubMed ID: 8421830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats.
    Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1996 Jun; 46(6):567-71. PubMed ID: 8767345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triphenyltetrazolium chloride (TTC) as a marker for ischaemic changes in rat brain following permanent middle cerebral artery occlusion.
    Hatfield RH; Mendelow AD; Perry RH; Alvarez LM; Modha P
    Neuropathol Appl Neurobiol; 1991 Feb; 17(1):61-7. PubMed ID: 2057051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.